📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial. (2016)

First Author: Todd JA

Attributed to: Adaptive Clinical Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002139

PubMed Identifier: 27727279

Publication URI: http://europepmc.org/abstract/MED/27727279

Type: Journal Article/Review

Volume: 13

Parent Publication: PLoS medicine

Issue: 10

ISSN: 1549-1277